Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Tamura

Showing results (81-90 of 140) with videos related to

Pageof 14
Sort By:
Nano Letters|May 5, 2021
Ultrasmall Downconverting Nanoparticle for Enhanced Cerenkov ImagingQize Zhang, Edwin C Pratt, Ryo Tamura, et al.
Clinical and Experimental Nephrology|February 21, 2020
High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney functionAiko Okubo, Ayumu Nakashima, Shigehiro Doi, et al.
ACS Medicinal Chemistry Letters|August 20, 2025
GPepT: A Foundation Language Model for Peptidomimetics Incorporating Noncanonical Amino AcidsYuna Oikawa, Takanori Uzawa, Francois Berenger, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2021
Cell-type-specific, multicolor labeling of endogenous proteins with split fluorescent protein tags in <i>Drosophila</i>Rie Kamiyama, Kota Banzai, Peiwei Liu, et al.
Advanced Therapeutics|January 12, 2026
ROS-activatable Prodrug of Doxazolidine as Novel Cancer Therapy ParadigmRyo Tamura, Chace I Carpenter, Charlotte M Thomas, et al.
Reproduction (Cambridge, England)|March 21, 2026
Genomic profiling of meiotic errors and early malignant transformation events in ovarian mature teratomaKotaro Takahashi, Ryo Tamura, Kazuaki Suda, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 17, 2023
Population pharmacokinetics and exposure-clinical outcome relationship of remdesivir major metabolite GS-441524 in patients with moderate and severe COVID-19Ryo Tamura, Kei Irie, Atsushi Nakagawa, et al.
The Biochemical Journal|December 13, 2022
Construction of mouse cochlin mutants with different GAG-binding specificities and their use for immunohistochemistryKarin Murakami, Ryo Tamura, Sanae Ikehara, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 22, 2021
Population pharmacokinetics of favipiravir in patients with COVID-19Kei Irie, Atsushi Nakagawa, Hirotoshi Fujita, et al.
Science Advances|March 9, 2022
De novo creation of a naked eye-detectable fluorescent molecule based on quantum chemical computation and machine learningMasato Sumita, Kei Terayama, Naoya Suzuki, et al.
Pageof 14

Showing results (81-90 of 140) with videos related to

Sort By:
Pageof 14
Nano Letters|May 5, 2021
Ultrasmall Downconverting Nanoparticle for Enhanced Cerenkov ImagingQize Zhang, Edwin C Pratt, Ryo Tamura, et al.
Clinical and Experimental Nephrology|February 21, 2020
High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney functionAiko Okubo, Ayumu Nakashima, Shigehiro Doi, et al.
ACS Medicinal Chemistry Letters|August 20, 2025
GPepT: A Foundation Language Model for Peptidomimetics Incorporating Noncanonical Amino AcidsYuna Oikawa, Takanori Uzawa, Francois Berenger, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2021
Cell-type-specific, multicolor labeling of endogenous proteins with split fluorescent protein tags in <i>Drosophila</i>Rie Kamiyama, Kota Banzai, Peiwei Liu, et al.
Advanced Therapeutics|January 12, 2026
ROS-activatable Prodrug of Doxazolidine as Novel Cancer Therapy ParadigmRyo Tamura, Chace I Carpenter, Charlotte M Thomas, et al.
Reproduction (Cambridge, England)|March 21, 2026
Genomic profiling of meiotic errors and early malignant transformation events in ovarian mature teratomaKotaro Takahashi, Ryo Tamura, Kazuaki Suda, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 17, 2023
Population pharmacokinetics and exposure-clinical outcome relationship of remdesivir major metabolite GS-441524 in patients with moderate and severe COVID-19Ryo Tamura, Kei Irie, Atsushi Nakagawa, et al.
The Biochemical Journal|December 13, 2022
Construction of mouse cochlin mutants with different GAG-binding specificities and their use for immunohistochemistryKarin Murakami, Ryo Tamura, Sanae Ikehara, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 22, 2021
Population pharmacokinetics of favipiravir in patients with COVID-19Kei Irie, Atsushi Nakagawa, Hirotoshi Fujita, et al.
Science Advances|March 9, 2022
De novo creation of a naked eye-detectable fluorescent molecule based on quantum chemical computation and machine learningMasato Sumita, Kei Terayama, Naoya Suzuki, et al.
Pageof 14